Molecular targets in cholestasis caused by bile salt export pump deficiency
胆盐输出泵缺陷引起的胆汁淤积的分子靶点
基本信息
- 批准号:10456780
- 负责人:
- 金额:$ 32.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:ABCB1 geneATP-Binding Cassette TransportersAccountingAdultAgeAlternative TherapiesAnimal ModelAnimalsAttenuatedAutophagocytosisBile AcidsBile fluidChildCholestasisCytoplasmDataExcretory functionExhibitsGenesGeneticGoalsHealthHepatocyteHeterozygoteHumanImpairmentIn VitroKnockout MiceKnowledgeLifeLiverLiver diseasesMembraneMissionModelingMolecularMolecular TargetMutationNeonatalOrthologous GeneOutcomePatient-Focused OutcomesPatientsPhenotypePrimary carcinoma of the liver cellsProgressive intrahepatic cholestasisPublic HealthPumpResearchSeveritiesSirolimusTestingTrehaloseUnited States National Institutes of HealthVesicleZebrafishbasebile saltsdesigndisabilityearly onsetend stage liver diseaseexperimental studygenome sequencinghepatocyte injuryimprovedin vivoinfancyinnovationliver injuryliver transplantationmTOR Inhibitormutantnew therapeutic targetnovelnovel strategiesnovel therapeuticspredictive markerprematurerestorationtargeted treatmentwhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT
In humans, mutations in the ABCB11 gene impair bile salt export pump (BSEP) function and cause
progressive familial intrahepatic cholestasis type II (PFIC2), which is a fast-progressing and often-fatal liver
disease in infancy. Liver transplantation remains as the only curable treatment for many PFIC2 patients.
The main challenge for developing alternative therapy is that there is no known mechanism allowing
restoration of bile excretion in the absence of BSEP. Our long-term goal is to discover molecular targets to
treat cholestatic liver diseases. The overall objective for this application is to identify mechanisms that can
be activated to restore bile excretion in the context of BSEP deficiency. Based on the preliminary data
generated using the abcb11b mutant zebrafish, the central hypothesis is that alternative transporters can be
prompted to excrete bile acids in BSEP-deficient hepatocytes. The rationale for the proposed research is
that, finding the alternative bile salt transporter and delineating the molecular mechanisms triggering its bile
excretion function will facilitate the designing of targeted therapies to treat cholestasis caused by BSEP
deficiency. Identifying novel strategies to modulate bile secretion will also benefit the patients with other
cholestatic liver diseases. The central hypothesis will be tested by the experiments proposed in three
complementary specific aims: 1) Determine the alternative transporter that can be prompted to excrete bile
acids in BSEP-deficient hepatocytes; 2) Define the cellular and molecular mechanisms that can be activated
to restore bile excretion in BSEP-deficient hepatocytes; and 3) Identify genetic modifiers that restore bile
excretion in BSEP-deficient hepatocytes. The first aim will test the hypothesis that recovering the
localization of another ABC transporter MDR1 to the bile canaliculus allows it to assume bile excretion
function in BSEP-deficient hepatocytes. The second aim will investigate whether augmentation of
autophagy represents a novel mechanism to restore bile excretion in hepatocytes with BSEP deficiency.
The third aim will utilize an unbiased whole-genome sequencing approach to identify genetic modifiers of
BSEP-deficiency phenotype severity. The research proposed in this application is highly innovative,
because it uses the zebrafish model that offers unique advantages for studying bile excretion, and abcb11b
mutant zebrafish is the first animal model in which loss of BSEP results in severe perturbation of bile
excretion as seen in patients with PFIC2. The proposed research is significant, because it is expected to
reveal strategies to restore bile excretion in BSEP-deficient hepatocytes and uncover new therapeutic
targets for treating cholestatic liver diseases.
项目总结/摘要
在人类中,ABCB 11基因突变损害胆盐输出泵(BSEP)功能,并导致
进行性家族性肝内胆汁淤积II型(PFIC 2),这是一种快速进展且经常致命的肝脏疾病,
婴儿期的疾病肝移植仍然是许多PFIC 2患者唯一可治愈的治疗方法。
开发替代疗法的主要挑战是没有已知的机制允许
在不存在BSEP的情况下恢复胆汁排泄。我们的长期目标是发现分子靶点,
治疗胆汁淤积性肝病。本申请的总体目标是确定能够
在BSEP缺乏的情况下被激活以恢复胆汁排泄。根据初步数据,
使用abcb 11b突变体斑马鱼产生的,中心假设是替代转运蛋白可以是
促使BSEP缺陷肝细胞分泌胆汁酸。拟议研究的基本原理是
找到替代的胆盐转运体并描绘触发其胆汁的分子机制,
排泄功能将有助于设计治疗BSEP引起的胆汁淤积的靶向治疗方法
缺陷确定调节胆汁分泌的新策略也将使患有其他疾病的患者受益。
胆汁淤积性肝病中心假设将通过三个实验中提出的实验进行检验。
补充的具体目标:1)确定可促使胆汁排泄的替代转运蛋白
BSEP缺陷肝细胞中的酸; 2)定义可以被激活的细胞和分子机制
恢复BSEP缺陷肝细胞中的胆汁排泄;和3)鉴定恢复胆汁分泌的遗传修饰剂
BSEP缺陷肝细胞中的排泄。第一个目标将测试恢复
另一种ABC转运蛋白MDR 1定位于胆小管,使其承担胆汁排泄
在BSEP缺陷肝细胞中的功能。第二个目标将调查是否增加
自噬是BSEP缺乏时肝细胞胆汁分泌恢复的一种新机制。
第三个目标将利用无偏倚的全基因组测序方法来鉴定遗传修饰剂,
BSEP缺陷表型严重程度。本申请中提出的研究具有高度创新性,
因为它使用了斑马鱼模型,为研究胆汁排泄提供了独特的优势,
突变斑马鱼是第一个BSEP缺失导致胆汁严重扰动的动物模型
在PFIC患者中观察到的排泄2。这项研究意义重大,因为它有望
揭示恢复BSEP缺陷肝细胞中胆汁排泄的策略,并发现新的治疗方法
用于治疗胆汁淤积性肝病的靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chunyue Yin其他文献
Chunyue Yin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chunyue Yin', 18)}}的其他基金
Modeling Progressive Familial Intrahepatic Cholestasis Type I Caused by ATP8B1 deficiency
ATP8B1 缺乏引起的进行性家族性肝内胆汁淤积 I 型建模
- 批准号:
10722357 - 财政年份:2023
- 资助金额:
$ 32.85万 - 项目类别:
Molecular targets in cholestasis caused by bile salt export pump deficiency
胆盐输出泵缺陷引起的胆汁淤积的分子靶点
- 批准号:
9789255 - 财政年份:2018
- 资助金额:
$ 32.85万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8788863 - 财政年份:2014
- 资助金额:
$ 32.85万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
9015723 - 财政年份:2014
- 资助金额:
$ 32.85万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8164707 - 财政年份:2011
- 资助金额:
$ 32.85万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8580763 - 财政年份:2011
- 资助金额:
$ 32.85万 - 项目类别:
相似海外基金
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10390366 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10237095 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
ATP Binding Cassette Transporters in Health and Disease
健康和疾病中的 ATP 结合盒转运蛋白
- 批准号:
10552563 - 财政年份:2021
- 资助金额:
$ 32.85万 - 项目类别:
Photosensitizing Nanoconstructs for Regulation of ATP-Binding Cassette Transporters in the Brain
用于调节大脑中 ATP 结合盒转运蛋白的光敏纳米结构
- 批准号:
2030253 - 财政年份:2020
- 资助金额:
$ 32.85万 - 项目类别:
Standard Grant
Structural and functional studies of iron uptake ATP-binding cassette transporters (ABC transporters) in Gram-negative bacteria
革兰氏阴性菌中铁摄取 ATP 结合盒转运蛋白(ABC 转运蛋白)的结构和功能研究
- 批准号:
20K22561 - 财政年份:2020
- 资助金额:
$ 32.85万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2018
- 资助金额:
$ 32.85万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2017
- 资助金额:
$ 32.85万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Investigating the mechanism of polysaccharide recognition and export by bacterial ATP-binding cassette transporters
研究细菌 ATP 结合盒转运蛋白识别和输出多糖的机制
- 批准号:
489384-2016 - 财政年份:2016
- 资助金额:
$ 32.85万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The Mechanism of ATP Binding Cassette Transporters
ATP 结合盒转运蛋白的机制
- 批准号:
318360 - 财政年份:2014
- 资助金额:
$ 32.85万 - 项目类别:
Fellowship Programs
Heat shock protein 27 attenuates foam cell formation by enhancing cholesterol efflux via the ATP-binding cassette transporters A1
热休克蛋白 27 通过 ATP 结合盒转运蛋白 A1 增强胆固醇流出,从而减弱泡沫细胞形成
- 批准号:
304334 - 财政年份:2014
- 资助金额:
$ 32.85万 - 项目类别: